Decoy Therapeutics is trading at $2.82 (-5.37%), with no clear catalyst identified.
- No new company-specific announcement, filing, earnings release, or major event was identified for September 3, 2026.
- Recent indexed items include financing and pipeline updates, but neither directly explains the decline.
- Broader markets are mixed: the S&P 500 is up 0.06%, Nasdaq is down 0.08%, and Dow is up 0.20%; no clear company, sector, or global catalyst emerged.